Ardigen will take part in BioTrinity 2018 in London

Topic:

Starting from Monday, the 23rd of April, our experts: EVP & Director of Microbiome Unit Kaja Milanowska and EVP & Director of Immuno-Oncology Unit Rafał Urniaż will participate in the #BioTrinity2018 in London. If you are passionate about the next generation healthcare and precision medicine, join the presentation titled:

“Ardigen’s #AIempowering #immunotherapy and #microbiome” on the 24th of April, at 11:25 am, in the Plenary Hall Two.

More about the event

Ardigen’s attendance at this conference is subsidized with the funds from the ProBio Małopolska project, which is co-financed by the European Union under the European Regional Development Fund, carried out on the basis of the project co-financing agreement No. RPMP.03.03.01-12-0121 / 16-00. The trip is organized with the assistance of Klaster LifeScience Kraków.

You might be also interested in:

,
Blog cover for Ardigen publication on ARDisplay-I and MHC ligand identification in Molecular & Cellular Proteomics
New publication in MCP: Improving MHC ligand identification with machine learning and optimized isolation
Fluorescence microscopy image of cells stained with multiple Cell Painting dyes showing cellular organelles in green, blue, and pink, overlaid with Ardigen brand graphic elements indicating phenomics data in durg discovery
End to End Data-to-Decision Journey for AI-Driven Phenomics in Drug Discovery
Abstract network visualization representing AI-driven integration of biological data and knowledge graphs for target identification in drug discovery.
Target Identification: From Poor Data to Quality Predictions
Abstract data streams representing data sourcing in pharmaceutical research and AI drug discovery
What Are Common Data Sourcing Patterns in Pharmaceutical Research (part 3)

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!